Sort   by:  
 Page size 
UnknownPioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis.
Not available
S-EPMC2928471 | biostudies-literature
UnknownEffect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial.
Not available
S-EPMC3110082 | biostudies-literature
UnknownVitamin E and changes in serum alanine aminotransferase levels in patients with non-alcoholic steatohepatitis.
Not available
S-EPMC3775262 | biostudies-literature
UnknownRelationship between adipose tissue insulin resistance and liver histology in nonalcoholic steatohepatitis: a pioglitazone versus vitamin E versus placebo for the treatment of nondiabetic patients with nonalcoholic steatohepatitis trial follow-up study.
Not available
S-EPMC3432683 | biostudies-literature
UnknownTreatment of nonalcoholic fatty liver disease in children: TONIC trial design.
Not available
S-EPMC2936451 | biostudies-literature
UnknownComplexity of ballooned hepatocyte feature recognition: Defining a training atlas for artificial intelligence-based imaging in NAFLD.
Not available
S-EPMC10544770 | biostudies-literature
UnknownRelationship between resolution of non-alcoholic steatohepatitis and changes in lipoprotein sub-fractions: a post-hoc analysis of the PIVENS trial.
Not available
S-EPMC6461513 | biostudies-literature
UnknownNASH resolution is associated with improvements in HDL and triglyceride levels but not improvement in LDL or non-HDL-C levels.
Not available
S-EPMC4424085 | biostudies-literature
UnknownImprovement in liver histology is associated with reduction in dyslipidemia in children with nonalcoholic fatty liver disease.
Not available
S-EPMC4341955 | biostudies-literature
UnknownAdjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer.
Not available
S-EPMC5538020 | biostudies-literature
Sort   by:  
 Page size